[
    [
        {
            "time": "",
            "original_text": "【太平洋化工】新和成19年报及20一季报点评：维生素竞争格局改善，二季度业绩预计持续向好",
            "features": {
                "keywords": [
                    "新和成",
                    "维生素",
                    "竞争格局",
                    "二季度",
                    "业绩",
                    "向好"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【太平洋化工】新和成19年报及20一季报点评：维生素竞争格局改善，二季度业绩预计持续向好",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【西南证券—新和成年报点评】维生素景气全面回升，公司业绩迎来高增长",
            "features": {
                "keywords": [
                    "新和成",
                    "维生素",
                    "景气",
                    "回升",
                    "业绩",
                    "高增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【西南证券—新和成年报点评】维生素景气全面回升，公司业绩迎来高增长",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "新和成一季度净利增长近八成 产品量价齐升年内或成常态",
            "features": {
                "keywords": [
                    "新和成",
                    "一季度",
                    "净利",
                    "增长",
                    "量价齐升",
                    "常态"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新和成一季度净利增长近八成 产品量价齐升年内或成常态",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]